Last reviewed · How we verify
Commercial tablet with water — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Commercial tablet with water (Commercial tablet with water) — Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Commercial tablet with water TARGET | Commercial tablet with water | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Commercial tablet with water CI watch — RSS
- Commercial tablet with water CI watch — Atom
- Commercial tablet with water CI watch — JSON
- Commercial tablet with water alone — RSS
Cite this brief
Drug Landscape (2026). Commercial tablet with water — Competitive Intelligence Brief. https://druglandscape.com/ci/commercial-tablet-with-water. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab